FDA has agreed to review Gliatech's ADCON-P....
From: Helen Dynda (firstname.lastname@example.org)
Tue Jun 20 12:34:19 2000
April 6, 2000 - Gliatech Announces Acceptance of Premarket Approval Modular Review Process for ADCON-P.
Gliatech's ADCON-P is a proprietary, resorbable, carbohydrate polymer liquid designed to inhibit postsurgical scarring and adhesions following gynecological pelvic surgery. The company is conducting a pivotal trial for ADCON-P at approximately 20 sites and in more than 200 patients undergoing minimally invasive gynecological surgery.